by Raynovich Rod | May 29, 2014 | 2025 Rayno Biopharmaceuticals Portfolio
Update 6/4 Snap- back rally and big green screen! Update 6/3….. Daily Performance-from list below 9 winners, 12 losers Rayno Biopharmaceutical Picks in bold— Winners: AGIO, INCY, SGEN, EPZM, MDVN, IMGN, GILD. CELG, PCYC. Losers: CLVS, ARIA, NLNK,CLDX,...
by Raynovich Rod | May 20, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Rally Developing-Green Screen Alert If you are underweight large cap biotech add FBT ($76.38) up 2%. Most of our large cap picks are up today: ABBV ALXN, BIIB,GILD,REGN. Reverse pattern from tuesday’s downdraft. ————– One of the...
by Raynovich Rod | May 20, 2014 | 2025 Rayno Biopharmaceuticals Portfolio
Rayno Life Science Focus Stocks: ARIA, IMGN, PCYC Ariad (ARIA) Abstracts Several data presentations will be made for Iclusig (Ponatinib) for leukemias and AP26113 its investigational oral inhibitor of anaplastic lymphoma kinase (ALK). A breakfast meeting featuring...
by Raynovich Rod | May 14, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update May 30-Fidelity Select Biotech (FBIOX) Fund is lagging Top ETFs FBT and IBB Compared to 2013 when FIDO beat the ETFs it is lagging post February bubble and YTD. It would be difficult to analyze why this happened but my guess is that: FIDO went chasing...
by Raynovich Rod | May 2, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Note: Prices are updated as of 10/6/14 Stocks on the list that are lower from 5/2 are: ALKS, ARIA,CBST, IMGN (dropped)-all others are up. Biotech Stocks Are Down 5-10% in April-IBB is up only 1% YTD but 32% over one year May 2 Mid-day trading: NASDAQ 41358 up 0.25%,...
by Raynovich Rod | May 1, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update August 5, 2014 Large Cap Biopharmaceutical Stocks Includes Q1 Earnings Reports (except REGN due 5/8) Rayno Focus Picks: ALXN, AMGN, BIIB, FBT, GILD, REGN, RHHBY Large cap stocks are core holdings especially now that sector momentum is easing. ABBV dropped...
by Raynovich Rod | Apr 22, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Rayno Life Science Stocks -Green Screen Rules-NASDAQ (4168) Up 1.16% Speculative ETF XBI (134.50) up 4.69% and 7.88% over 5 days; 52 week high $172.52. ETF PBE ($40.85) up over 3%. Momentum stocks are soaring but way off all time highs in February. Big Rayno...
by Raynovich Rod | Apr 21, 2014 | 2025 Rayno Biopharmaceuticals Portfolio
Biotech Stocks Have A Strong Day-April 15 Bottom Holding Rayno Life Science Portfolios Stick with larger caps through earnings: ABBV, AMGN, ALKS, BIIB, GILD. MOMO mid cap stocks coming back today: INCY MDVN PBYI plus many others. Losers- Cepheid (CPHD and...
by Raynovich Rod | Apr 11, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Top Ten Reasons For Biotech Correction NASDAQ at 4022,IBB at 221 A Sentiment Driven Market We have been writing about the bull market in biotech stocks since its inception in March 2009 when quality companies were advancing their pipelines and new products in...
by Raynovich Rod | Apr 9, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update 4/10 Abrupt Sell-Off –Failure to Confirm Bottom NASDAQ down 71 pts 1.7% All of yesterdays’ gains wiped out and we are back to January levels. Raise cash levels to 30% on life science portfolios. Many high fliers and core holdings are selling off...
